22. Punnonen R, Vaajalahti P, Teisala K. Department of Obstetrics and Gynaecology,
University Central Hospital, Tempere, Finland. Local Oestriol Treatment Improves the Structure of Elastic Fibers in the Skin of Post-Menopausal Women. Clinical Trial. Ann Chir Gynaecol Suppl 1987;202:39-41.
23. Tercan M, Cokkeser Y, Ozyazgan I, Bekerecioglu M, Sari I. Department of Plastic and Reconstructive Surgery, Gaziantep University, Turkey. Facilitated Tissue Expansion with Topical Estriol. Ann Plast Surg 2001 Jun;46(6):617-20.
24.Kainz C, Gitsch G, Stani J, Breitenecker G, Binder M, Schmidt JB. 2nd Department
of Gynecology and Obstetrics, University of Vienna, School of Medicine, Austria. When Applied to Facial Skin, Does Estrogen Ointment Have Systemic Effects? Arch Gynecol Obstet 1993;253(2):71-4.
25.Iosif, CS. Department of Obstetrics and Gynecology, University of Lund, Sweden.
Effects of Protracted Administration of Estriol on the Lower Genito Urinary Tract in Post-Menopausal Women. Arch Ghyecol Obstet 1992;251(3):115-20.
26.Lose G, Englev E. Department of Obstetrics and Gynaecology, Glostrup County
Hospital, Copenhagen University, Denmark. Oestradiol-Releasing Vaginal Ring Versus Oestriol Vaginal Pessaries in the Treatment of Bothersome Lower Urinary Tract Symptoms. Clinical Trial. BJOG 2000 Aug;107(8):1029-34.
27. Chlebowski, Rowan T. MD PhD. Reducing the Risk of Breast Cancer.
(“Tamoxiphen”) Harbor-UCLA Research and Education Institute, Torrance California. Volume 343, Number 3, July 20, 2000.
28.Takahashi K, Okada M, Ozaki T, Kurioka H, Manabe A, Kanasaki H, Miyazaki K.
Safety and Efficacy of Oestriol for Symptoms of Natural or Surgically Induced Menopause. Clinical Trial. Hum Reprod 2000 May; 15(5):1028-36.
29.Schmidt JB, Binder M, Demschik G, Bieglmayer C, Reiner A. Department of
Dermatology, University of Vienna Medical School, Austria. Treatment of Skin Aging with Topical Estrogens. Clinical Trial. Int J Dermatol 1996 Sep;35(9):669-74.
30.Tzingounis VA, Aksu MF, Greenblatt RB. Estriol in the Management of the
Menopause. Jama 1978 Apr 21;239(16):1638-41.
31.Hayashi T, Ito I, Kano H, Endo H, Iguchi A. Department of Geriatrics, Nagoya
University School of Medicine, Japan. hayashi@med.nagoya-u.ac.jp. Estriol (E3) Replacement Improves Endothelial Function and Bone Mineral Density in Very Elderly Women. Clinical Trial. J Gerontol A Biol Sci Med Sci 2000 Apr;55(4):B183-90;Discussion B191-3.
32.Manonai J, Theppisai U. Department of Obstetrics and Gynecology, Faculty of
Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. Effect of Oral Estriol on Urogenital Symptoms, Vaginal Cytology, and Plasma Hormone Level in Post-Menopausal Women. J Med Assoc Thai 2001 Apr;84(4):539-44.
33.Cherdshewasart W, Kitsamai Y, Malaivijitnond S. Evaluation of the Estrogenic Activity of the Wild Pueraria Mirifica by Vaginal Cornification Assay. Journal of Reproduction and Development, Vol. 53 (2007), No. 2, April pp.385-393.
34. Longcope C. Estriol Production and Metabolism in Normal Women. J Steroid Biochem 1984 Apr;20(4B):959-62.
35. Granberg S, Eurenius K, Lindgren R, Wilhelmsson L. Department of Obstetrics and Gynecology, Central Hospital, Elverum, Norway, seth.granberg@telia.com. The Effects of Oral Estriol on the Endometrium in Post-Menopausal Women. Clinical Trial. Maturitas 2002 Jun 25;42(2):149-56.
36. Yoshimura T, Okamura H. Department of Obstetrics and Gynecology, Kumamoto University School of Medicine, Honjo 1-1-1, 860-8556, Kumamoto Japan. yoshimur@kaiju.medic.kumamoto-u.ac.jp. Short-Term Oral Estriol Treatment Restores Normal Pre-Menopausal Vaginal Flora to Elderly Women. Maturitas 2001 Sep 28;39(3):253-7.
37. Takahashi K, Manabe A, Okada M, Kurioka H, Kanasaki H, Miyazaki K. Department of Obstetrics and Gynecology, Shimane Medical University, Izumo Japan. taka27@shimane-med.ac.jp. Efficacy and Safety of Oral Estriol for Managing Post-Menopausal Symptoms. Maturitas 2000 Feb 15;34(2):169-77.
38. Itoi H, Minakami H, Iwasaki R, Sato I. Clinical Trial. Department of Obstetrics and Gynecology, Jichi Medical School, Minamikawachi-machi, 329-04, Tochigi, Japan. Comparison of the long-term effects of oral estriol with the effects of conjugated estrogen on serum lipid profile in early menopausal women. Clinical Trial. Maturitas 2000 Oct 31;36(3):217-22.
39. Schmidt JB, Binder M, Macheiner W, Kainz C, Gitsch G, Bieglmayer C. Department of Special and Environmental Dermatology, University of Vienna Medical School, Wien Austria. Treatment of Skin Ageing Symptoms in Peri-Menopausal Females with Estrogen Compounds. A pilot study. Maturitas 1994 Nov;20(1):25-30.
40. Haspels AA, Luisi M, Kicovic PM. Endocrinological and Clinical Investigations in Post-Menopausal Women Following Administration of Vaginal Cream Containing Oestriol. Maturitas 1981 Dec;3(3-4)L321-7.
41. Kuramoshi Professor, Smitasiri Y Assoc Professor. School of Medicine, Saint Mariane University, Tokyo Japan, School of Science, Mae Fah Luang University, Chiang Rai Thailand. Preliminary study of Pueraria Mirifica in Japanese. Mid-February and 1st Week August 1999.
42. Melamed M, Castano E, Notides AC, Sasson S. Department of Pharmacology, School of Pharmacy, Faculty of Medicine, Hebrew University of Jerusalem, Israel. Molecular and Kinetic Basis for the Mixed Agonist/Antagonist Activity of Estriol. Mol Endocrinol 1997 Nov;11(12):1868-78.
43. Ritchie M PhD MRSC, Young, R PhD MNIMH. Protocol for Assessment of
Mechanism of Action of Pueraria Mirifica on the Alpha and Beta Receptor of a Selected Breast Cancer Cell Line. Napier University August 4, 2007. (CONFIDENTIAL)
44.Koloszar S, Kovacs L. Szent-GyorgyiAlbert Orvostudomanyi Egyetem,
Szuleszeties Nogyogyaszati Klinika, Szeged. [Treatment of Climacteric Urogenital
Disorders with an Estriol-Containing Ointment] - [Article in Hungarian]. Orv Hetil 1995 Feb 12;136(7):343-5.
45. Chandeying V. MD, Sangthawan M. MD. Faculty of Medicine, Prince of Songkhla
University, Hat Yai, Songkla, Hat Yai Regional Hospital, Hat Yai, Songkla.
Efficacy Comparison of Pueraria Mirifica (PM) Against Conjugated Equine
Estrogen (CEE)With/Without Medroxyprogesterone Acetate (MPA) in the Treatment of Climacteric Symptoms in Perimenopausal Women: Phase III Study. J Med Assoc Thai 2007; 90 (9): 1720-6.
46.Chandeying V. MD, Lamlertkittikul S, Lamlertkittikul P, Schauss Alex. Faculty of
Medicine Prince of Songkla University, Hat Yai, Thailand, Hat Yai Center Hospital, Hat Yai, Thailand. Efficacy and Safety of Pueraria Mirifica (Kwao Keur Kao) for the Treatmen of Vasomotor Symptoms in Perimenopausal Women: Phase II Study.
47.Smitasiri Yuthana, Professor, Mae Fah Luang University, Chiang Rai, Thailand Are White Kwao Krew Products Interesting for Use? September 13, 2002
48.Somkhit Banomyong. Secrets of Pueraria Mirifica Revealed April 11, 2001
49. Premarket Notification for Pueraria Candollei var. Mirifica Root Extract As a Dietary Ingredient. A Paper
50. The Science Behind Pueraria Mirifica. A Paper
51. Thai Patents on Kwao Krua (Pueraria Mirifica). Book Excerpt, Pages 51-54.
52.The Ingredient of Pueraria Tuberous Root. Luang Anusarnsoondhorn Upasipong; Printing May 15, 1931
53. Revision of the Genus Pueraria DC. With Some Notes On Teyleria Backer. (Leguminosae) Van Der Maesen, L.J.G. Agricultural University Wageningen, The Netherlands 1985.
54.Subcharoen, Pennapa, Deputy Director-General, Department for Development of Thai Traditional and Alternative Medicine, Chthaputti, Anchalee, Senior Pharmacist, Institute of Thai Traditional Medicine, Ministry of Public Health, Thailand. Thai Traditional Medicine Kingdom of Thailand
55.Pilling David, Bardacke Ted. Genetic Pirates Walk the Plank. Financial Times, January 9, 1999 Page 7.
56. Pueraria Mirifica “Kwao Kreu Kao” Rejuvenating Herbal Products. Thailand Medicinal Plant Research Institute, Department of Medical Sciences, Ministry of Public Health, Thailand July 2000.
57.Subcharoen Pannapa Dr., Jaidee Vichaya Mrs. Thai Wisdom for Global Health.
The Thai Traditional Medicine Development Foundation Ministry of Public Health, Thailand July 2004
58.Mirhom Yossef , Ph.D. Pueraria Mirifica “The Miracle Root”.
| 
